Going Wiki, 23andMe Using Web to Recruit Customers for Disease-Risk and ADR Trials
June 04, 2008
Going Wiki, 23andMe Using Web to Recruit Customers for Disease-Risk and ADR Trials
The initiative, called 23andWe, aims to improve the quality of patient data that enter pharmacogenomic-based clinical trials organized by 23andMe; advance the development of tailored drugs; and encourage regulators and medical groups to use genetic information in their medical decision making.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Q&A: INMEGEN's Alfredo Hidalgo on Using Genomics to Address Mexico's Most Pressing Health Problems
May 17, 2013 / BioArray News - European Consortium Investigating Molecular Basis of IBD
May 17, 2013 / GenomeWeb Daily News - GMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell Lines
May 17, 2013 / ProteoMonitor - Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
May 17, 2013 / ProteoMonitor - NIDDK to Fund Biomarker, Assay Projects Using Samples and Data from Its Repository
May 17, 2013 / GenomeWeb Daily News